Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

5.61
Delayed Data
As of Dec 09
 +0.13 / +2.37%
Today’s Change
4.39
Today|||52-Week Range
9.02
-28.99%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues21.4M21.3M33.7M28.1M
 
 
 
 
 
Cost of Goods Sold46.0K711.0K1.9M1.0M
 
 
 
 
 
Depreciation And Amortization--1.5M1.5M2.2M
 
 
 
 
 
Operating ExpensesGross Income21.4M19.0M30.3M24.9M
 
 
 
 
 
General Expenses64.1M49.1M60.2M47.9M
 
 
 
 
 
Research And Development44.7M32.9M41.0M32.1M
 
 
 
 
 
Total Operating Expenses64.1M51.4M63.5M51.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-42.7M-30.1M-29.9M-23.1M
 
 
 
 
 
Extraordinary Charge0.000.00-14.6M-15.4M
 
 
 
Interest Expense On Debt5.7M8.6M6.6M0.00
 
 
 
 
Other Expenses337.0K-43.0K-64.0K385.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-48.1M-38.7M-51.0M-30.3M
 
 
 
 
 
Minority Interest-242.0K-185.0K-208.0K-207.0K
 
 
 
 
 
Net Income-47.8M-38.5M-50.8M-30.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS115.6M116.1M126.2M129.2M
 
 
 
 
 
Shares To Calculate EPS Diluted115.6M116.1M126.2M129.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.41-$0.33-$0.40-$0.23
 
 
 
 
 
EPS Diluted-$0.41-$0.33-$0.40-$0.23